Low prevalence of anti-RNA polymerase III antibodies in a French scleroderma population. Anti-RNA polymerase III scleroderma

European Journal of Internal Medicine

Volumn 21, Issue 2, 2010, Pages 114-117

  Faucher, Benoit ^a   Stein, Philippe ^b   Granel, Brigitte ^a   Weiller, Pierre Jean ^c   Disdier, Patrick ^c   Serratrice, Jacques ^c   Harlé, Jean Robert ^b   Durand, Jean Marc ^b   Frances, Yves ^a   Guis, Sandrine ^b   Pham, Thao ^b   Bardin, Nathalie ^b   Sanmarco, Marielle ^b  

^a HÔPITAL NORD   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

^c TIMONE HOSPITAL   (France)

Author keywords

Anti RNA polymerase III antibodies; ELISA; Scleroderma; Systemic Sclerosis

Indexed keywords

ANTIBODY; CENTROMERE ANTIBODY; DNA DIRECTED RNA POLYMERASE III; DNA DIRECTED RNA POLYMERASE III ANTIBODY; DNA TOPOISOMERASE; MARKER; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRANCE; HUMAN; IMMUNOPRECIPITATION; MALE; POPULATION RESEARCH; PREVALENCE; RHEUMATOID ARTHRITIS; SCLERODERMA; SYSTEMIC SCLEROSIS; VIRUS INFECTION;

AGED; ANTIBODIES, ANTINUCLEAR; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CASE-CONTROL STUDIES; CENTROMERE; DNA TOPOISOMERASES, TYPE I; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FRANCE; HUMANS; IMMUNOPRECIPITATION; MALE; MIDDLE AGED; PREVALENCE; RNA POLYMERASE III; SCLERODERMA, SYSTEMIC;

EID: 77549088634     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2010.01.004     Document Type: Article

References (21)

1. Mayes M.D., Lacey J.V., Beebe-Dimmer J., et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 48 (2003) 2246-2255
2. Tan E.M., Rodnan G.P., Garcia I., Moroi Y., Fritzler M.J., and Peebles C. Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome. Arthritis Rheum 23 (1980) 617-625
3. Reveille J.D., and Solomon D.H. Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies. Arthritis Rheum 49 (2003) 399-412
4. Bunn C.C., Denton C.P., Shi-Wen X., Knight C., and Black C.M. Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis. Br J Rheumatol 37 (1998) 15-20
5. Kuwana M., Okano Y., Kaburaki J., Medsger T.A., and Wright T.M. Autoantibodies to RNA polymerases recognize multiple subunits and demonstrate cross-reactivity with RNA polymerase complexes. Arthritis Rheum 42 (1999) 275-284
6. Kuwana M., Kaburaki J., Mimori T., Tojo T., and Homma M. Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis. J Clin Invest 91 (1993) 1399-1404
7. Kuwana M., Kimura K., and Kawakami Y. Identification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera: application to enzyme-linked immunosorbent assay. Arthritis Rheum 46 (2002) 2742-2747
8. Kuwana M., Okano Y., Kaburaki J., Tojo T., and Medsger T.A. Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies. Arthritis Rheum 37 (1994) 902-906
9. Kuwana M., Okano Y., Pandey J.P., Silver R.M., Fertig N., and Medsger T.A. Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody: analytical accuracy and clinical associations in systemic sclerosis. Arthritis Rheum 52 (2005) 2425-2432
10. Okano Y., Steen V.D., and Medsger T.A. Autoantibody reactive with RNA polymerase III in systemic sclerosis. Ann Intern Med 119 (1993) 1005-1013
11. Santiago M., Baron M., Hudson M., Burlingame R.W., and Fritzler M.J. Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA. J Rheumatol 34 (2007) 1528-1534
12. Parker J.C., Burlingame R.W., Webb T.T., and Bunn C.C. Anti-RNA polymerase III antibodies in patients with systemic sclerosis detected by indirect immunofluorescence and ELISA. Rheumatology (Oxford) 47 (2008) 976-979
13. Chang M., Wang R.J., Yangco D.T., et al. Analysis of autoantibodies against RNA polymerases using immunoaffinity-purified RNA polymerase I, II, and III antigen in an enzyme-linked immunosorbent assay. Clin Immunol Immunopathol 89 (1998) 71-78
14. Meyer O.C., Fertig N., Lucas M., Somogyi N., and Medsger T.A. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis. J Rheumatol 34 (2007) 104-109
15. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23 (1980) 581-590
16. LeRoy E.C., Black C., Fleischmajer R., et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15 (1988) 202-205
17. Arnett F.C. Revised criteria for the classification of rheumatoid arthritis. Bull Rheum Dis 38 (1989) 1-6
18. Codullo V., Morozzi G., Bardoni A., et al. Validation of a new immunoenzymatic method to detect antibodies to RNA polymerase III in systemic sclerosis. Clin Exp Rheumatol 25 (2007) 373-377
19. Bardoni A., Rossi P., Salvini R., Bobbio-Pallavicini F., Caporali R., and Montecucco C. Autoantibodies to RNA-polymerases in Italian patients with systemic sclerosis. Clin Exp Rheumatol 21 (2003) 301-306
20. Kuwana M., Pandey J.P., Silver R.M., Kawakami Y., and Kaburaki J. HLA class II alleles in systemic sclerosis patients with anti-RNA polymerase I/III antibody: associations with subunit reactivities. J Rheumatol 30 (2003) 2392-2397
21. Dick T., Mierau R., Bartz-Bazzanella P., et al. Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis. Ann Rheum Dis 61 (2002) 121-127